For patients hospitalized for COVID-19, administration of therapeutic-dose vs prophylactic-dose anticoagulation with heparins ...

risks of anticoagulant therapy, and the costs of diagnosis and the treatment of VTE. Data Extraction: I analyzed references cited in reviews and meta-analyses of VTE, and from Medline searches ...

Objective. To provide the pediatric intensivist an in-depth understanding of citrate as regional anticoagulant during continuous renal replacement therapy. Data Sources and Data Selection.

Despite guidelines recommending other anticoagulants for people hospitalized with acute pulmonary embolism (PE), old habits ...

Unfractionated heparin is used for both therapeutic anticoagulation and for maintaining vascular catheter patency via heparin locks and flushes.LMWH is used for therapeutic anticoagulation.

Cadrenal Therapeutics (CVKD) recapped its 2024 milestones and highlighted a clear path forward to develop the investigational drug tecarfarin ...

REGN7508 proved the most successful of the two, with a single dose of the therapy demonstrating its superiority to daily doses of the approved factor Xa-targetting anticoagulant enoxaparin ...

The researchers found that 28-day mortality was reduced with therapeutic-dose versus prophylactic-dose anticoagulation with heparins (odds ratio, 0.77; 95 percent confidence interval, 0.64 to 0.93 ...

Fewer thromboembolic events were seen in association with higher- vs lower-dose anticoagulation, but the risk for major bleeding was greater. (HealthDay News) — For patients hospitalized for ...